Downloadable Slides

Share

Program Content

Activities

  • TROP2 ADC Overview
    Antibody‒Drug Conjugates and Their Role in TROP2-Expressing Tumors
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2023

  • TROP2 ADC Efficacy
    Clinical Data on TROP2-Targeting ADCs in Breast, Urothelial, and Lung Cancers
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2023

  • TROP2 ADC Toxicity
    Identification and Management of Adverse Events With TROP2-Targeting ADCs
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 28, 2023

Faculty

cover img faculity

Elise Hitron, MSN, FNP-C

Nurse Practitioner
Phase I Clinical Trials at Winship Cancer Institute
Atlanta, Georgia

cover img faculity

Srigowri Kota, MSN, BA, APRN, AGNP-C, OCN

Nurse Practitioner
Department of Genitourinary Medical Oncology
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey

cover img faculity

Neelima Vidula, MD

Assistant Professor of Medicine
Harvard Medical School
Attending Physician
Department of Medical Oncology
Massachusetts General Hospital
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc. 

Gilead Sciences, Inc.